Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptotagmin-14 (SYT14) is a protein-coding gene and a member of the synaptotagmin family, which is involved in membrane trafficking and exocytosis of secretory vesicles, particularly in non-neuronal tissues. Unlike classical synaptotagmins, SYT14 is calcium-independent. Mutations in SYT14 cause autosomal recessive spinocerebellar ataxia 11 (SCAR11) and have been associated with neurodevelopmental disorders such as macrocephaly, cerebral atrophy, seizures, and developmental delay. SYT14 is thought to function through interactions involving protein heterodimerization and may share functional similarities with other synaptotagmins involved in vesicle trafficking in synaptic transmission[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptotagmin-14 (SYT14).